Arturo Araya

Arturo Araya is Cellares’ Executive Vice President of Commercialization, currently leading and executing on the go-to-market strategy for the Cell Shuttle, an automated and closed end-to-end manufacturing solution for scaling cell therapies. He joined the company in 2023 with over a decade of executive experience commercializing cell and gene therapies. Notably, Araya served as Chief Commercial Officer for Novartis’ cell therapy unit during the early development of Kymriah, as well as Vice President for Global Commercial Strategy for several multi-billion dollar Novartis Oncology products. Previous roles also include Chief Commercial Officer of Brainstorm Cell Therapeutics, Chief Commercial Officer at cell and gene therapy COI/COC software developer TrakCel, and Associate Director of Marketing Research and Business at Bristol-Meyers Squibb.